JENNIFER LONG: Open Payments
NPI 1164515169 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 36 payments from 13 companies in 2025. Trend: 2023 $316 · 2024 $394 · 2025 $738
Food & beverage: $639Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $118 |
| Lilly USA, LLC | 5 | $88 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Hologic Sales and Service, LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| MILLICENT US INC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $19 |
Products named: ENTYVIO, MYFEMBREE, Auvelity, Veozah, MOUNJARO, MYOSURE TISSUE REMOVAL DEVICE, FEMLYV, NOVASURE.
Industry payments across LA — which companies pay providers there.
